Inventor · disambiguated record
Christopher Mark Hill
Also filed as: HILL CHRISTOPHER MARK · HILL CHRISTOPHER P
0 granted patents·8 pending applications·0 citations·filing 2002–2025
Top patents by PatentIndex Score
8 records- 0181US2024150459A1Anti-LAG-3 Antibodies to Treat Hematological MalignanciesBRISTOL MYERS SQUIBB CO·Filed 2023·Application pending·0 cites
- 0271US2025197495A1Anti-lag-3 antibodies to treat hematological malignanciesBRISTOL MYERS SQUIBB CO·Filed 2025·Application pending·0 cites
- 0369US2021122820A1Anti-LAG-3 Antibodies to Treat Hematological MalignanciesBRISTOL MYERS SQUIBB CO·Filed 2020·Application pending·0 cites
- 0459US2018244773A1Anti-lag-3 antibodies to treat hematological malignanciesBRISTOL MYERS SQUIBB CO·Filed 2018·Application pending·0 cites
- 0551US2025345431A1Genetically engineered t cells expressing a cd19 chimeric antigen receptor (car) and uses thereof for allogeneic cell therapyJUNO THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 0650US2016326248A1Anti-lag-3 antibodies to treat hematological malignanciesBRISTOL MYERS SQUIBB CO·Filed 2015·Application pending·0 cites
- 0748US2025376536A1Multispecific anti-cd40 / anti-fap antibodies and uses thereofBRISTOL MYERS SQUIBB CO·Filed 2025·Application pending·0 cites
- 0842US2005009743A1In vitro assays for inhibitors of hiv capsid conformational changes and for hiv capsid formationFiled 2002·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Christopher Mark Hill files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →